Carregant...
Healthcare utilization and steroid-refractory toxicities from immune checkpoint inhibitors
BACKGROUND: Anti-programmed death-1 (PD-1) agents have transformed the treatment of advanced melanoma and other cancers, but the rates of steroid-refractory toxicities and healthcare utilization are not well-described. We assessed these endpoints in melanoma patients treated with anti-PD-1 +/− ipili...
Guardat en:
| Publicat a: | Cancer |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6952563/ https://ncbi.nlm.nih.gov/pubmed/31580492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32542 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|